KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $6,722,000 | +71.7% | 37,386 | -1.0% | 0.01% | +60.0% |
| Q2 2017 | $3,916,000 | +62.3% | 37,773 | +22.9% | 0.01% | +66.7% |
| Q1 2017 | $2,413,000 | +99.1% | 30,745 | +13.7% | 0.00% | +50.0% |
| Q4 2016 | $1,212,000 | -19.4% | 27,035 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $1,503,000 | +12.1% | 26,901 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $1,341,000 | +48.5% | 26,813 | +31.3% | 0.00% | +100.0% |
| Q1 2016 | $903,000 | -23.8% | 20,419 | +6.2% | 0.00% | 0.0% |
| Q4 2015 | $1,185,000 | +11.7% | 19,234 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,061,000 | -6.4% | 19,053 | +2.5% | 0.00% | 0.0% |
| Q2 2015 | $1,133,000 | +181.1% | 18,584 | +166.0% | 0.00% | 0.0% |
| Q1 2015 | $403,000 | +7.8% | 6,986 | +7.7% | 0.00% | 0.0% |
| Q4 2014 | $374,000 | +6133.3% | 6,488 | +3064.9% | 0.00% | – |
| Q3 2014 | $6,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |